financetom
Business
financetom
/
Business
/
Five Point-backed WaterBridge eyes up to $2.3 billion valuation in US IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Five Point-backed WaterBridge eyes up to $2.3 billion valuation in US IPO
Sep 8, 2025 7:13 AM

(Reuters) - WaterBridge is seeking a valuation of up to $2.28 billion in its initial public offering in the U.S., the oilfield water management company said on Monday, underscoring strengthening momentum in the new listings market.

U.S. listings have rebounded from a slump in April sparked by tariff-driven market volatility, as signs of progress in trade negotiations and resilient investor demand restored confidence in the market.

The Five Point-backed company said it would sell 27 million shares, priced between $17 and $20 apiece, to raise as much as $540 million.

Houston, Texas-based WaterBridge is a pure-play water infrastructure firm mainly operating in the Delaware Basin. It is involved in gathering, transporting, recycling and handling produced water for oil exploration and production firms.

The listing comes more than a year after the New York debut of fellow Five Point-backed LandBridge, with which WaterBridge partners to use underutilized pore space in the Delaware Basin to meet rising water-handling demand.

Its customers include BPX Energy, Chevron, Devon Energy, EOG Resources and Permian Resources.

Asset manager Horizon Kinetics has indicated interest in buying up to $120 million worth of shares in the offering.

J.P. Morgan and Barclays are the lead underwriters for the offering.

WaterBridge will list on the New York Stock Exchange and NYSE Texas under the symbol "WBI."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Starts Phase 2/3 Trial of Surufatinib Combination Therapy in Pancreatic Cancer
Hutchmed Starts Phase 2/3 Trial of Surufatinib Combination Therapy in Pancreatic Cancer
May 14, 2024
05:54 AM EDT, 05/14/2024 (MT Newswires) -- Hutchmed ( HCM ) said Tuesday it started a phase 2/3 trial of its drug candidate surufatinib in combination with nab-paclitaxel, gemcitabine and Jiangsu Hengrui's camrelizumab as a first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma in China. The company said the trial's first patient received the first dose on May 8...
Anglo American eyes break-up as it fends off BHP bid
Anglo American eyes break-up as it fends off BHP bid
May 14, 2024
LONDON, May 14 (Reuters) - Anglo American laid out plans on Tuesday for a potential break-up of the group via a demerger or sale of its steelmaking coal, nickel, diamonds and platinum businesses as it tries to fend off a takeover bid from BHP Group ( BHP ). The announcement comes a day after the London-listed miner rejected a raised...
Merchants Bancorp Prices $98 Million Common Stock Offering
Merchants Bancorp Prices $98 Million Common Stock Offering
May 14, 2024
05:45 AM EDT, 05/14/2024 (MT Newswires) -- Merchants Bancorp ( MBIN ) said late Monday it has priced an underwritten public offering of 2.4 million common shares at $43 per share for expected proceeds of about $98 million. The company also granted the underwriters a 30-day option to buy up to an additional 360,000 shares. The company said it plans...
--Waste Management Maintains Dividend at $0.75 per Share, Payable on June 21 to Shareholders of Record on June 7
--Waste Management Maintains Dividend at $0.75 per Share, Payable on June 21 to Shareholders of Record on June 7
May 14, 2024
05:50 AM EDT, 05/14/2024 (MT Newswires) -- Price: 210.99, Change: +0.17, Percent Change: +0.08 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved